BioNTech SE (BSP:B1NT34)
R$ 29.34 -0.51 (-1.71%) Market Cap: 118.71 Bil Enterprise Value: 34.00 Bil PE Ratio: 0 PB Ratio: 1.07 GF Score: 53/100

Q1 2026 Biontech SE Earnings Call Transcript

May 05, 2026 / 12:00PM GMT
Release Date Price: R$29.64 (-3.83%)
Operator

Welcome to BioNTech's first-quarter 2026 earnings call. I will now have the call over to Doug Maffei, Vice President - Strategy and Investor Relations. Please go ahead.

Douglas Maffei
Biontech SE - Vice President - Investor Relations

Thank you, operator. Good morning and good afternoon. Thank you for joining BioNTech's first-quarter 2026 earnings call. As a reminder, the slides we will use during this call and the corresponding press release can be found in the Investors section of our website.

On the next slide, you will see our forward-looking statements disclaimer. Additional information about these statements and other risks are described in our filings with the US Securities and Exchange Commission or SEC. Forward-looking statements on this call are subject to significant risks and uncertainties and speak only as of the date of this conference call. We undertake no obligation to update or revise any of these statements. On slide 3, you can find the agenda for today's call.

I'm joined by the following members of BioNTech's management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot